Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Santhera Pharmaceuticals Holding AG SPHDF

Full chart Compare
Set alert

Price alert · SPHDF

All alert types
18.30 USD 0.00 (+0.00%)

At closeOct 30, 2026, 4:00 PM EDT

22.85 Day range 22.85
12.28 52-week range 23.25
YTD
+37.08%
1 year
+49.14%

Financial health

Altman Z-Score

-4.84 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.8×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: -0.0×FY 2020: -0.0×FY 2021: -79.1×FY 2022: -112×FY 2023: 1.9×FY 2024: -2.3×FY 2025: -2.8×
FY 2016 5y median -2.8× FY 2025
P/S 1.8×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: -2754×FY 2022: 1062×FY 2023: 1.0×FY 2024: 2.5×FY 2025: 1.8×
FY 2016 5y median 1.8× FY 2025
P/B -11.7×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -0.0×FY 2021: 3308×FY 2022: -182×FY 2023: 1.7×FY 2024: 3.5×FY 2025: -11.7×
FY 2016 5y median 1.7× FY 2025
P/FCF -4.0×
FY 2016: -0.0×FY 2017: -0.0×FY 2018: -0.0×FY 2019: 0.0×FY 2020: -0.0×FY 2021: -118×FY 2022: -235×FY 2023: 4.4×FY 2024: -2.7×FY 2025: -4.0×
FY 2016 5y median -4.0× FY 2025
EV/EBITDA -6.6×
FY 2016: 1.7×FY 2017: -0.2×FY 2018: -0.7×FY 2019: -4.5×FY 2020: -1.1×FY 2021: -128×FY 2022: -171×FY 2023: 1.2×FY 2024: -6.1×FY 2025: -6.6×
FY 2016 5y median -6.6× FY 2025
EV/Sales 2.8×
FY 2016: -2.6×FY 2017: 0.3×FY 2018: 1.0×FY 2019: 0.5×FY 2020: 3.9×FY 2021: -2767×FY 2022: 1068×FY 2023: 0.9×FY 2024: 2.5×FY 2025: 2.8×
FY 2016 5y median 2.5× FY 2025
FCF Yield -25.3%
FY 2016: -9984513.2%FY 2017: -24002172.6%FY 2018: -1457880.7%FY 2019: 18243723.7%FY 2020: -1175980234.2%FY 2021: -0.9%FY 2022: -0.4%FY 2023: 22.6%FY 2024: -36.7%FY 2025: -25.3%
FY 2016 5y median -0.9% FY 2025

Profitability

Gross Margin 18.7%
FY 2016: 79.6%FY 2017: 82.1%FY 2018: 85.1%FY 2019: 92.8%FY 2020: 30.5%FY 2021: 336.2%FY 2022: 51.9%FY 2023: 96.9%FY 2024: 58.7%FY 2025: 18.7%
FY 2016 5y median 58.7% FY 2025
Operating Margin -49.0%
FY 2016: -174.1%FY 2017: -219.9%FY 2018: -162.4%FY 2019: -13.9%FY 2020: -353.7%FY 2021: 3566.6%FY 2022: -695.5%FY 2023: 66.6%FY 2024: -85.3%FY 2025: -49.0%
FY 2016 5y median -49.0% FY 2025
Net Margin -63.8%
FY 2016: -186.1%FY 2017: -224.6%FY 2018: -171.2%FY 2019: -25.2%FY 2020: -450.8%FY 2021: 3481.3%FY 2022: -951.1%FY 2023: 53.0%FY 2024: -107.3%FY 2025: -63.8%
FY 2016 5y median -63.8% FY 2025
ROE 416.7%
FY 2016: -47.6%FY 2017: -159.8%FY 2018: -194.7%FY 2019: -89.3%FY 2020: 1064.8%FY 2021: -4181.2%FY 2022: 162.7%FY 2023: 91.4%FY 2024: -151.5%FY 2025: 416.7%
FY 2016 5y median 91.4% FY 2025
ROIC -37.5%
FY 2016: -41.1%FY 2017: -52.3%FY 2018: -56.8%FY 2019: -10.7%FY 2020: -74.8%FY 2021: -76.6%FY 2022: -140.2%FY 2023: 79.2%FY 2024: -29.3%FY 2025: -37.5%
FY 2016 5y median -37.5% FY 2025
ROA -33.2%
FY 2016: -39.0%FY 2017: -46.9%FY 2018: -49.1%FY 2019: -16.5%FY 2020: -76.3%FY 2021: -60.9%FY 2022: -111.5%FY 2023: 50.0%FY 2024: -27.5%FY 2025: -33.2%
FY 2016 5y median -33.2% FY 2025

Growth (YoY)

Revenue 97.4%
FY 2016: 340.5%FY 2017: 20.5%FY 2018: 38.0%FY 2019: 138.1%FY 2020: -80.1%FY 2021: -110.6%FY 2022: 568.5%FY 2023: 1283.8%FY 2024: -62.2%FY 2025: 97.4%
FY 2016 FY 2025
Operating Income -13.3%
FY 2016: -1144.0%FY 2017: -52.3%FY 2018: -1.9%FY 2019: 79.7%FY 2020: -408.3%FY 2021: -7.2%FY 2022: 8.6%FY 2023: 232.5%FY 2024: -148.5%FY 2025: -13.3%
FY 2016 FY 2025
EPS (diluted) -2.4%
FY 2016: -622.7%FY 2017: -45.6%FY 2018: 4.3%FY 2019: 78.0%FY 2020: -194.4%FY 2021: 68.0%FY 2022: 28.2%FY 2023: 142.9%FY 2024: -173.7%FY 2025: -2.4%
FY 2016 FY 2025
Free Cash Flow 2.4%
FY 2016: -20.1%FY 2017: -49.1%FY 2018: -45.0%FY 2019: 104.0%FY 2020: -1940.4%FY 2021: 14.2%FY 2022: 9.6%FY 2023: 169.6%FY 2024: -251.6%FY 2025: 2.4%
FY 2016 FY 2025

Financial Health

Current Ratio 1.3×
FY 2016: 6.1×FY 2017: 5.9×FY 2018: 2.2×FY 2019: 2.1×FY 2020: 0.6×FY 2021: 0.8×FY 2022: 0.1×FY 2023: 0.8×FY 2024: 1.6×FY 2025: 1.3×
FY 2016 5y median 0.8× FY 2025
Quick Ratio 0.9×
FY 2016: 5.3×FY 2017: 5.1×FY 2018: 1.7×FY 2019: 1.8×FY 2020: 0.6×FY 2021: 0.7×FY 2022: 0.1×FY 2023: 0.7×FY 2024: 1.3×FY 2025: 0.9×
FY 2016 5y median 0.7× FY 2025
Debt / Equity -8.3×
FY 2016: 0.0×FY 2017: 1.6×FY 2018: 2.0×FY 2019: 3.1×FY 2020: -11.2×FY 2021: 32.4×FY 2022: -1.0×FY 2023: 0.4×FY 2024: 1.5×FY 2025: -8.3×
FY 2016 5y median 0.4× FY 2025
Net Debt / EBITDA -2.3×
FY 2016: 1.7×FY 2017: -0.2×FY 2018: -0.7×FY 2019: -4.5×FY 2020: -1.1×FY 2021: -0.6×FY 2022: -0.9×FY 2023: -0.1×FY 2024: -0.0×FY 2025: -2.3×
FY 2016 5y median -0.6× FY 2025
Interest Coverage -3.3×
FY 2016: -2208×FY 2017: -13.1×FY 2018: -11.4×FY 2019: -1.7×FY 2020: -7.7×FY 2021: -3.5×FY 2022: -2.6×FY 2023: 3.2×FY 2024: -1.7×FY 2025: -3.3×
FY 2016 5y median -2.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31